Christopher Gee, MD
Retina Specialist · West Jordan, UTNPI 1831372499
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 94.7% of the total across 115 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 17 manufacturers reported payments, led by Regeneron Healthcare Solutions, Inc. at 27.3% of the total. 2025 is the largest year on record at $790, 6.4 times the $123 reported in 2019.
Across 115 payments — averaging $23.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Regeneron Healthcare Solutions, Inc.$747
- Genentech USA, Inc.$630
- AbbVie$330
- Apellis Pharmaceuticals, Inc.$154
- Astellas Pharma US Inc$154
- Astellas Pharma Global Development$152
- plus $565 from 11 others
What the payments were for
- Food & beverage$2,58895%
- Education$1445%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 31 | $747 |
| Genentech USA, Inc. | 31 | $630 |
| AbbVie(2 entities) | 17 | $330 |
| Apellis Pharmaceuticals, Inc. | 2 | $154 |
| Astellas Pharma US Inc | 6 | $154 |
| Astellas Pharma Global Development | 3 | $152 |
| Immunocore Limited | 4 | $102 |
| Alimera Sciences, Inc. | 6 | $87 |
| Eyepoint US, Inc. | 3 | $70 |
| Biogen | 3 | $70 |
| Lumibird Medical Inc. | 1 | $60 |
| Neurotech Pharmaceuticals, Inc. | 1 | $44 |
| Novartis | 2 | $36 |
| Cardinal Health 108 LLC | 2 | $31 |
| Idorsia Pharmaceuticals US Inc | 1 | $23 |
| Coherus Oncology, Inc. | 1 | $21 |
| Harrow Eye, LLC | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Syfovre$122
How this compares
$2,732 in reported general payments places this provider in the 55th percentile of 20 retina specialist providers in Utah.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Prednisolone Acetate | 115 | $3,984 |
| MoxifloxacinMoxifloxacin Hcl | 81 | $1,839 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 39 | $426 |
| Diclofenac Sodium | 27 | $343 |
| Latanoprost | 44 | $300 |
| Timolol Maleate | 21 | $279 |
| Ketorolac Tromethamine | 11 | $175 |
Paid to pharmacies, not to this prescriber.
Other retina specialist in West Jordan
- Andrew DavisWest Jordan$4K
- Douglas MehrWest Jordan$3K
- Robert KwunSalt Lake City$334K
- Mitchell GoffSalt Lake City$165K
- James HowardSalt Lake City$14K
- David FaberSalt Lake City$10K
- Rebekah GensureSalt Lake City$5K
- Joshua CarlsonSt George$3K
- Kirk WinwardSalt Lake City$3K
- Eric BrintonSalt Lake City$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.